Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.65 |
| ▸ | POLB | P06746 | 2/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 2/20 | 0.57 |
| ▸ | NPC1 | O15118 | 3/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.51 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.51 |
| ▸ | RELA | Q04206 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | PYGM | P11217 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29348787 | 0.83 | KMT2A (0.57) | RAB9ASMN1; SMN2ALDH1A1L3MBTL1KDM4E | |
| SCHEMBL5550226 | 0.83 | SMN1; SMN2 (0.60) | RAB9APOLBSMN1; SMN2ALDH1A1L3MBTL1 | |
| SCHEMBL11277786 | 0.83 | SMN1; SMN2 (0.68) | RAB9ASMN1; SMN2ALDH1A1L3MBTL1KDM4E | |
| SCHEMBL28321600 | 0.81 | SMN1; SMN2 (0.70) | RAB9APOLBSMN1; SMN2L3MBTL1KDM4E | |
| SCHEMBL20332878 | 0.81 | SMN1; SMN2 (0.55) | RAB9ASMN1; SMN2ALDH1A1L3MBTL1KDM4E | |
| SCHEMBL3890906 | 0.80 | SMN1; SMN2 (0.62) | RAB9APOLBSMN1; SMN2ALDH1A1L3MBTL1 | |
| SCHEMBL1233477 | 0.79 | SMN1; SMN2 (0.58) | RAB9ASMN1; SMN2ALDH1A1L3MBTL1KDM4E | |
| SCHEMBL5070509 | 0.79 | SMN1; SMN2 (0.58) | RAB9ASMN1; SMN2ALDH1A1L3MBTL1KDM4E | |
| SCHEMBL29477055 | 0.79 | SMN1; SMN2 (0.58) | RAB9ASMN1; SMN2ALDH1A1L3MBTL1KDM4E | |
| SCHEMBL22468550 | 0.79 | SMN1; SMN2 (0.58) | RAB9ASMN1; SMN2ALDH1A1L3MBTL1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020198053-A1 | 2-OXO-2,3-DIHYDRO-1H-IMIDAZO[4,5-B]PYRIDIN-6-YL)-4-METHYLBENZAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS RIPK2 INHIBITORS FOR TREATING E.G. AUTOIMMUNE DISEASES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2020-10-01 | — | — | WO | claimed |
| EP-2334674-A1 | PYRIDAZINO- PYRIDINONE COMPOUNDS FOR THE TREATMENT OF PROTEIN KINASE MEDIATED DISEASES. | Amgen, Inc (US) | 2011-06-22 | — | — | EP | claimed |
| WO-2010025201-A1 | PYRIDAZINO- PYRIDINONE COMPOUNDS FOR THE TREATMENT OF PROTEIN KINASE MEDIATED DISEASES. | AMGEN INC. (US) | 2010-03-04 | — | — | WO | claimed |
| EP-2280943-A1 | NEW SUBSTITUTED SPIROÝCYCLOALKYL-1,3'-INDOL¨-2'(1'H)-ONE DERIVATIVES AND THEIR USE AS P38 MITOGEN-ACTIVATED KINASE INHIBITORS. | Almirall, S.A. (ES) | 2011-02-09 | — | — | EP | disclosed |
| WO-2009124692-A1 | NEW SUBSTITUTED SPIRO[CYCLOALKYL-1,3'-INDOL]-2'(1'H)-ONE DERIVATIVES AND THEIR USE AS P38 MITOGEN-ACTIVATED KINASE INHIBITORS. | ALMIRALL, S.A. (ES) | 2009-10-15 | — | — | WO | disclosed |